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Outcomes of carotid artery stenting versus
historical surgical controls for radiation-induced
carotid stenosis
Tiziano Tallarita, MD,a Gustavo S. Oderich, MD,a Giuseppe Lanzino, MD,b Harry Cloft, MD,c
David Kallmes, MD,c Thomas C. Bower, MD,a Audra A. Duncan, MD,a and
Peter Gloviczki, MD,a Rochester, Minn
Purpose: To evaluate the outcomes of carotid artery stenting (CAS) and open surgical repair (OR) for treatment of
radiation-induced carotid stenosis (RICS).
Methods: We retrospectively reviewed 60 patients treated for 73 RICSs from a group of 5,824 patients who had carotid
interventions between 1992 and 2009. Thirty-three patients (37 arteries) were treated with CAS and 27 patients (36
arteries) with OR. CAS was performed using embolic protection as part of a prospective institutional registry since 2003.
End-points included mortality, stroke, myocardial infarction (MI), cranial nerve injury (CNI), wound complication,
restenosis, and reintervention.
Results:Demographics and cardiovascular risk factors were similar in both groups, with the exception of higher rates (P<
.05) of hyperlipidemia (81% vs 56%) and coronary artery disease (63% vs 33%) in OR patients. There were more patients
with tracheostomy (31% vs 4%) and time interval from irradiation to intervention was longer in the CAS group. There
were no early deaths. At 30 days, ORwas associated with one (3%) stroke, two (5.5%)MIs, six (17%) CNIs, and three (8%)
wound complications. OR patients with prior radical neck dissections had more wound complications (14% vs 5%) and
CNIs (28% vs 9%) compared with those without neck dissections. In the CAS group, there were two (6%) strokes and no
MIs, CNIs, or wound complications. Mean length of hospital stay was longer after OR than CAS (4.1 3.7 days vs 2.4
2.1 days; P .02). Median follow-up was 58 months. At 7 years, OR was associated with higher patient survival (75%
15% vs 29% 13%, P .008) and freedom from neurological events (100% vs 57% 9.5%, P .058), but similar freedom
from restenosis (80%  10% vs 72%  9%) and reinterventions (87%  10% vs 86%  9%) compared with CAS.
Conclusion: Carotid artery stenting for radiation-induced stenosis has the advantages of no CNI or wound complications
with similar early stroke rate compared with open carotid repair. However, the lower freedom from neurological events
may offset the early benefits of carotid stenting in patients who are considered good candidates for open surgery. (J Vasc
Surg 2011;53:629-36.)
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tCervical irradiation is often employed for treatment of
head and neck cancers. The ionizing effect of radiation
causes arteritis, which may lead to stenosis, thrombosis,
fibrosis, or acceleration of atherosclerosis.1-3 Radiation-
induced lesions often affect long arterial segments and
atypical locations such as the proximal common carotid
artery.4 In addition, the deleterious effects of radiation to
the soft tissue and skin result in fibrosis, induration, and
ischemia. Open carotid reconstruction for radiation-
induced lesions has been associated with higher rates of
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doi:10.1016/j.jvs.2010.09.056troke, cranial nerve injury, and problems related to wound
ealing such as necrosis, infection, and skin breakdown.5,6
Carotid artery angioplasty and stenting (CAS) has clear
dvantages in this setting. It avoids the need to dissect
hrough scarred tissue and the potential risks of cranial nerve
njury or wound healing complications.4,6-13 However, the
nthusiasm with CAS has been tempered by high rates of
estenosis and reinterventions in the range of 4% to 51% in
ontemporary reports dealing with radiation-induced carotid
tenosis (RICS).4,8-10,6,12,13 The aim of this study was to
eview the outcomes of CAS and of a historical group treated
ith open carotid repair (OR) for RICS.
ETHODS
The study was approved by the Institutional Review
oard of the Mayo Clinic.
All patients treated for RICS with OR or CAS from 1992
o 2009 were identified. Patients treated with CAS after 2003
ere enrolled in a prospective institutional registry. We ex-
luded patients treated for restenosis, atherosclerosis without
history of prior radiation, or other forms of arteritis.
Demographics, cardiovascular risk factors, clinical pre-
entation, anatomical characteristics, imaging, and opera-
ive findings were reviewed. Early and late morbidity, mor-
ality, stroke, or transient ischemic attacks (TIA) were
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March 2011630 Tallarita et alnoted. Early postprocedure period was defined as occurring
within the first 30 days or within the hospital stay. Preop-
erative imaging studies, including carotid duplex ultra-
sound, computed tomography angiography (CTA), mag-
netic resonance angiography (MRA), and conventional
angiography, were reviewed to identify lesion characteris-
tics, including length, degree of stenosis, presence and
severity of calcification, thrombus, or ulceration. Carotid
revascularization was indicated in patients with progressive
asymptomatic carotid stenosis  80% or symptomatic le-
sions  50% using the North American Symptomatic Ca-
rotid Endarterectomy Trial criteria.15 Most patients with
asymptomatic lesions had an initial period of observation
with medical therapy, but revascularization was indicated
because of significant progression in the degree of stenosis.
Prior to 1999, OR was the only method used for revascu-
larization. Since then, patients were treated preferentially
with CAS, except when there was thrombus (Fig 1) or
excessive tortuosity of the aortic arch or carotid artery.
Open carotid repair
Open carotid reconstruction was performed under
general endotracheal anesthesia using electroencephalo-
graphic monitoring and selective in-line shunt. The type of
reconstruction was left at the discretion of the operating
surgeon. Carotid endarterectomy and patch was used pref-
erentially whenever possible (Fig 1), except for long lesions
or when the artery was friable or thin-walled, in which case
an interposition graft or bypass was preferred. Myocutane-
ous flap coverage was indicated if there was concern about
the quality of the radiated skin and soft tissue (Fig 2, online
Fig 1. A 78-year-old male patient presented with a high
thrombus (B, straight arrow) and new onset amaurosis fu
endarterectomy and patch angioplasty with Bovine peric
the common carotid artery with adjacent fresh thrombuonly). Medical therapy was aspirin alone in most patients. AS
CAS was performed using biplanar image under local
nesthesia with monitored care. Antiplatelet therapy (aspi-
in and clopidogrel) was started 1 week prior to the proce-
ure and continued for at least 6 weeks, after which clopi-
ogrel was discontinued unless there was residual or
ecurrent stenosis. Percutaneous trans-femoral access was
stablished with a 6 Fr hydrophilic guide catheter (Fig 3,
nline only). After systemic heparinization, arch and selec-
ive carotid and cerebral angiography were performed to
onfirm the degree of stenosis. The lesion was crossed using
n embolic protection device, predilated with a 4- to 5-mm
ngioplasty balloon, and stented with a nitinol self-expand-
ble stent. Postdilation was performed for residual stenoses
30%. Completion cervical and cerebral angiography was
btained after retrieval of the embolic protection device
Fig 3, online only). Heparinization was not reversed and
ll patients were monitored for 24 to 48 hours with inde-
endent neurological assessment and carotid duplex ultra-
ound (US) evaluation prior to dismissal.
ollow-up
Follow-up included clinical examination and carotid
uplexUS every 6months during the first year and annually
hereafter. Stroke and cranial nerve injury (CNI) were
onfirmed by independent neurological consultation. Ca-
otid duplex US criterion for restenosis50% was the same
or in-stent and for postsurgical restenosis. The criterion
ncluded peak systolic velocity of 220 cm/sec, internal
arotid artery (ICA) to common carotid artery (CCA) ratio
e carotid artery stenosis (A) with development of fresh
n a 2-week interval. The patient was treated with carotid
patch (C and D). Panel C shows high grade stenosis of
l to the area of stenosis.grad
gax o
ardial3.0, or doubling of velocities compared with baseline
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Volume 53, Number 3 Tallarita et al 631carotid US.14,15 Patients with restenoses were further eval-
uated by conventional angiography, CTA, or MRA, and
reintervention was indicated for symptomatic restenosis
50% or progressive asymptomatic lesions 80%.
End-points and statistical analysis
Clinical data was reported and analyzed using recom-
mended reporting standards.16 Outcomes were compared
in patients who had prior history of radical neck dissection
(radical neck dissection present [RND]) or not (RND).
The primary end point was a composite of any stroke,
myocardial infarction, and death; secondary end points
included morbidity and mortality, CNIs, wound complica-
tions (infection, necrosis, or dehiscence), and freedom
from restenosis, reintervention, and neurological events
(stroke and TIA). Patients with stroke/TIA had indepen-
dent neurological consultation, head CT or MR, and ca-
rotid duplex US.
Categorical variables were compared using Chi-square
Table 1. Clinical characteristics in 60 patients treated for 7
stenting (CAS) or open repair (OR)
C
n 
Demographics
Mean age (years)  SD 66.5
Male 25
Female 8
Cardiovascular risk factors
Hypertension 21
Hyperlipidemia 18
Cigarette smoking 21
Coronary artery disease 11
Diabetes mellitus 7
Chronic obstructive pulmonary disease 7
Peripheral artery disease 6
Atrial fibrillation 4
Chronic renal insufficiency 2
Dialysis 0
Anatomical risk factors
Dissection 24
Tracheostomy 10
Irradiation protocol
Higher dose protocol (60-75 Gy) 25
Nasopharyngeal/laryngeal cancer 20
Thyroid 1
Lung 4
Lower dose protocol ( 50 Gy) 8
Skin 4
Breast 0
Lymphoma 4
Year irradiation administered
1970-1989 17
1990-1999 9
2000-2009 7
Time from irradiation (months) 76
Indications
Asymptomatic stenosis  80% 18
Symptomatic stenosis  50% 19
Transient ischemic attack 16
Stroke 3or Fisher exact tests and continuous variables using two- (ailed, unpaired Student’s t test. Time-dependent out-
omes (survival, neurological events, restenosis, and rein-
erventions) were reported using Kaplan andMeier survival
stimates, and differences were compared using log-rank
nalysis. Univariate analysis was performed to identify pre-
ictors of primary and secondary end point measures, and a
ogistic regression model was used to identify independent
actors when indicated. Results were reported as mean 
tandard or median, or hazard ratio with 95% confidence
nterval (95% CI) when appropriate. A P value 0.05 was
onsidered statistically significant.
ESULTS
atient characteristics
A total of 5,824 patients had carotid interventions for
arotid stenosis during the study period. Of these, 60
atients (1%) underwent revascularization of 73 RICS,
ncluding 33 patients (37 lesions) treated with CAS and 27
diation-induced carotid stenosis with carotid artery
OR
n  27, % P value
5 66.5  11.6 .45
76 20 74 .72
24 7 26 .72
64 17 63 .97
56 22 81 .039
63 15 56 .75
33 17 63 .04
22 5 19 .75
22 8 30 .5
18 9 33 .2
13 3 11 .87
8 3 11 .5
0 0 0 1.0
73 11 31 .2
31 1 4 .02
76 18 67 .75
61 14 52 .7
3 3 11 .3
12 1 4 .4
24 9 33 .6
12 0 0 .1
0 1 4 .5
12 8 30 .2
52 16 59 .75
27 7 26 1.0
21 4 15 .75
21  17 .001
49 16 44 .61
51 20 56 .61
84 20 100 .71
16 0 0 .0863 ra
AS
33, %
 8.
 9336 lesions) treated with OR (Table I). Bilateral carotid
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March 2011632 Tallarita et alrevascularization was needed in four CAS and in nine OR
patients. The average age was 66 years, with similar cardio-
vascular risk factors, except for higher rates (P  .05) of
hyperlipidemia (56% vs 81%) and coronary artery disease
(33% vs 63%) among OR patients. Indications were asymp-
tomatic stenosis in 18 (49%) CAS and 16 (44%) OR pa-
tients, or symptomatic disease in 19 (51%) and 20 (56%),
respectively. Patients treated with CAS had more tracheos-
tomies (31% vs 4%) and longer time interval from irradia-
tion to intervention (76  93 months vs 21  17 months;
P .001). There were no significant differences in the type
of malignancy or year (before or after 1990) of irradiation
treatment between groups (Table I). A higher irradiation
dose (60 to 75 Gy) protocol for nasopharyngeal, laryngeal,
lung, and thyroid cancer was used in 25 (76%) CAS and 18
(67%) OR patients, whereas a lower irradiation dose ( 50
Gy) protocol for breast or skin cancer was indicated in eight
(24%) CAS and nine (33%) OR patients. Twenty-four
(73%) CAS and 11 (31%) OR patients had prior radical
neck dissections (P  .2).
Extent of carotid disease
Anatomic characteristics are summarized in Fig 4 and
Table II (online only). Isolated ICA lesions occurred in 20
(54%) CAS and 20 (56%) OR patients, and tandem lesions
or extensive involvement of both CCA and ICA was noted
in nine (25%) CAS and 12 (33%) OR patients. The lesion
was ulcerated in 15 (41%) CAS and 22 (61%) OR patients.
Fresh thrombus was noted in none of the CAS patients, but
occurred in five (14%) OR patients.
Carotid revascularization
Open carotid repair included carotid endarterectomy
and patch angioplasty for 29 lesions (80%), interposition
graft in five, and bypass in two (Table III, online only).
Myocutaneous flap coverage was needed in 3 of 14 lesions
(22%) in patients with RND, but in none of the RND
patients (P  .07). The surgeon referred in the operative
report to excessive scar in ten (28%) patients, including five
RND (36%) and five RND (23%), while endarterec-
tomy was difficult in one RND (7%) and six RND
(27%) patients. In the CAS group, embolic protection
device was used to treat 25 lesions (68%) in 23 patients, but
12 lesions (32%) in 10 patients were treated without em-
bolic protection prior to 2003. All patients had self-ex-
pandable stents, including 11 (25%) treated withWallstents
(Boston Scientific, Minneapolis, Minn) and 28 (62%) with
0.014-inch nitinol stents.
Early outcomes
There were no procedure-related deaths (Table IV).
The primary end point occurred in three CAS (9%) and
three OR (11%) patients (P  1.0). There were two (6%)
strokes after CAS and one (4%) after OR, all among RND
patients (P  1.0). In the symptomatic group, there was
one (5%) stroke after CAS and none after OR (P 1.0); for
asymptomatic patients, there was one stroke after CAS (6%)
and one after OR (5%). Two patients (7.4%) had non-Q- pave sub-endocardial infarctions without major complica-
ions after OR. Six (22%) OR patients had CNIs, including
of 14 (28%) RND and 2 of 22 (9%) RND lesions (P
.02). Wound complications after OR occurred in two
14%) RND and in one (5%) RND lesion (P  .55).
ean length of hospital stay was longer after OR compared
ith CAS (2.4 2.1 days versus 4.1 3.7 days; P .02).
ate outcomes
Thirty patients (91%) in the CAS group and 19 (70%;
 .5) in theOR group had clinical and imaging follow-up
t an average of 58 months (range, 1-132 months). Patient
urvival at 5 years was 40% 9% for CAS and 100% for OR
atients (Fig 5, online only; P  .008). There were 11 late
eaths (33%) after CAS due to malignancy in ten (30%)
atients and ipsilateral stroke in one patient (3%) who had
arotid stent occlusion 38 months later. In the OR group,
here were three late deaths due to malignancy, but none of
he patients died from cardiovascular cause.
Late strokes occurred in three (9%) patients (two
ND and one RND) after CAS and in none of the OR
ig 4. Distribution of carotid, subclavian, and vertebral arteries
tenosis in 60 patients who had undergone previous neck irradia-
ion.atients (P  .25). All three strokes were ipsilateral (two
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Volume 53, Number 3 Tallarita et al 633major and one minor), and two occurred in patients treated
for symptomatic lesions. Freedom from any neurological
event at 5 years was 90%  7% for CAS and 100% for OR,
reaching statistical significance at 7 years (Fig 6). Restenosis
50% occurred in eight patients (24%) treated with CAS (six
RND and two RND), including two patients who
developed stent occlusion, one fatal. All restenosis and
occlusions affected the stented segment; six were asymp-
tomatic and two presented with symptoms. Five patients
required reinterventions, which included redo CAS in three
or percutaneous angioplasty in two. In the OR group, four
patients (15%) had asymptomatic restenosis, including one
RND and three RND. Of these, two patients with
Table IV. Early outcomes in 60 patients treated for 73 ra
(CAS) or open repair (OR)
CAS
RND n  24
patients/28
lesions, %
RND
pati
lesi
Stroke 2 (8) 0
Myocardial infarction 0 (0) 0
Death 0 (0) 0
Stroke/death/myocardial
infarction
2 (8) 1
Cranial nerve injury 0 (0)b 0
Wound complication 0 (0) 0
Acute thrombosis 0 (0) 0
Dialysis 0 (0) 0
Intensive care unit stay (days) 1.3  0.6 1.0
Length in-hospital stay (days) 2.7  3.0b 2.2
RND, Radical neck dissection present (RND) or absent (RND).
aP value not statistically significant for comparison of totals between CAS an
bP  .02.
cP  .07.
Fig 6. Kaplan-Meier estimates for freedom from neurologic
event among 60 patients treated for radiation-induced carotid
stenosis with open carotid repair (OR, red) or carotid artery
stenting (CAS, black). The dotted line denotes a standard devia-
tion 10%.progressive asymptomatic lesions were treated with CAS. preedom from restenosis and reintervention at 5 years was
2%  9% and 86%  9% for CAS and 80%  10% and
7% 10% for OR (P .15 and P .30, respectively; Fig
A, 7B). Freedom from reintervention at 5 years was 80%
% and 100% for RND (P  .08), and 100% and 80% 
3% for RND patients (P  .2) treated by CAS and OR,
espectively.
ISCUSSION
Open carotid revascularization in patients with previ-
us neck irradiation has always been performed with trep-
dation. There is a legitimate concern that radiation predis-
oses patients to higher rates of stroke, cranial nerve injury,
nd wound complications including infection, necrosis, or
kin breakdown.5,6 Carotid angioplasty and stenting has
merged as a promising alternative to open surgery, avoid-
ng some of the challenges described above. This study
rovides the largest single-center analysis and the first out-
ome comparison between endovascular and open surgical
echniques for RICS.
Radiation has been accepted as a high-risk criterion for
arotid endarterectomy because of the complications de-
cribed above. Mozes and associates17 reported our expe-
ience with 776 consecutive carotid endarterectomies, in-
luding 323 patients (42%) who were considered high-risk
ased on clinical or anatomical factors. In that study, radi-
tion was the most important predictor of perioperative
troke, and local factors such as radiation, high carotid
ifurcation, and reoperation were associated with cranial
erve injury in 8% of patients. In this study, the rate of
ranial nerve injury was higher (17%), but compared favor-
bly with other reports dealing with carotid reoperations
7%-17%) or radiated wounds (up to 27%).5,18-30 We have
ound higher rates of cranial nerve injury (28% vs 9%) and
ound complications (14% vs 5%) among patients with
n-induced carotid stenosis with carotid artery stenting
OR
P valuea
9 RND n  11
patients/14
lesions, %
RND n  16
patients/22
lesions, %
1 (9) 0 (0) 1.0a
0 (0) 2 (12) 0.5a
0 (0) 0 (0) 1.0a
1 (9) 2 (12) 1.0a
4 (28)b 2 (9) .02
2 (14) 1 (4.5) .2a
0 (0) 1 (4.5) 1.0a
0 (0) 0 (0) 1.0a
1.5  2.0 1.3  1.0 .8a
5.2  4.7b,c 3.4  2.0c ‡b,c
patients; comparison of RND and RND patients were not significant.diatio
 n 
ents/9
ons, %
(0)
(0)
(0)
(12)
(0)
(0)
(0)
(0)
 0.4
 1.3
d ORrior radical neck dissections compared with those without
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March 2011634 Tallarita et alsuch a history, although some of the differences did not
reach statistical significance. A similarity to other reports is
the use of myocutaneous flaps in 27% of our patients with
prior neck dissections; along with others, we believe that
this helps prevent wound breakdown, which can expose the
arterial repair and lead to blowout of the anastomosis (Fig
2, online only).21
Recent studies have shown that open surgery can be
performed safely in selected patients with cervical irradia-
tion. Friedell et al reported 13 patients treated with carotid
endarterectomy for radiation-induced lesions, with no peri-
operative death, cranial nerve injury, or stroke after an
average follow-up of 37 months.24 Leseche and associates
reported the largest series to date, which included 27
patients with previous radiation treated with open surgery.
In that study, there was one perioperative death from
hemorrhage, one early TIA, no late neurological event, and
only two reinterventions.27 Similar to other reports, we
have found that open carotid repair can be performed safely
with no early death, and low stroke (4%) and restenosis
Fig 7. Kaplan-Meier estimates for freedom from restenosis (A) or
reintervention (B) among 60 patients treated for radiation-in-
duced carotid stenosis with open carotid repair (OR, red) or
carotid artery stenting (CAS, black).rates (11%).4,6-13,31-33 fConversely, carotid stents may not be as durable as open
arotid repair in the radiated neck. Protack et al12 reported
estenosis in 43% of 23 patients treated for radiation-induced
esions with carotid stenting, including two (8.5%) who had
tent occlusion. Favre and associates reported a retrospec-
ive review of 135 patients treated in multiple centers with
arotid stents for cervical irradiation. Although there were
o deaths and only two early strokes, six patients developed
ate strokes, nine had stent occlusions, and 18 developed
estenoses.6 Other reports have shown high restenosis rates
or carotid stents in the range of 12% to 42%.3,6,10 In our
tudy, we found a trend towards higher rates of restenosis
22% vs 11%) and reintervention (13.5% vs 5.5%) among
atients treated with CAS compared with open surgery,
lthough these differences were not significant. However,
imilar to others, we also found late stent occlusions in two
f our patients, one of which was fatal.3,6,10
In addition to this compelling data indicating that
arotid stents for radiation-induced lesions are not as dura-
le as open surgery, recent prospective randomized studies
ave shown higher stroke and death rates for carotid stents
ompared to endarterectomy. In the Carotid Revascular-
zation Endarterectomy versus Stenting Trial study, the
ncidence of stroke/death for carotid stenting versus end-
rterectomy was 6% and 3.2% for symptomatic, and 3.2%
nd 1.4% for asymptomatic lesions, respectively. Other
rospective randomized studies (Stent-protected Angio-
lasty versus Carotid Endarterectomy in Symptomatic Pa-
ients, Endarterectomy Versus Angioplasty in Patients with
ymptomatic Severe Carotid Stenosis, and International
arotid Stenting Study trial) have also shown higher
troke/death rates for CAS compared with endarterectomy
n the symptomatic group, questioning its indication for
hose patients who are good candidates for a carotid end-
rterectomy.34-36
The indication of any type of revascularization for
symptomatic carotid lesions remains controversial, partic-
larly in the higher risk group. The benefit of carotid
ndarterectomy in the Asymptomatic Carotid Atheroscle-
osis Study was modest, with only 1% annual stroke risk
eduction over 5 years.37 In addition, medical therapy in
he randomized trials did not include some of the current
reatment strategies that constitute best medical therapy
oday, such as strict control of hypertension, intensive lipid
owering therapy, and combined anti-platelet regimens. A
ecent population-based study on patients with asymptom-
tic carotid stenoses showed only a 0.34% annual risk of
psilateral stroke with intensive contemporary medical ther-
py over a mean follow-up of 3 years.38 It is possible that
ntensive medical therapy could have lowered the risk of
troke in the Asymptomatic Carotid Atherosclerosis Study
rial, potentially negating any benefit from carotid endar-
erectomy. Nonetheless, we still recommend revasculariza-
ion in a patient who has objective evidence of significant
rogression of a high-grade RICS.
The extent of radiation damage to the skin, soft tissue,
nd artery likely affect outcomes of revascularization. Un-
ortunately, previous reports dealing with radiation-
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Volume 53, Number 3 Tallarita et al 635induced lesions have not analyzed any of the surrogates for
radiation damage, such as type of radiation protocol, dose
administered, or prior radical neck dissection. Radiation
protocols have improved over time, mainly since the use of
two-dimensional (after 1990) and three-dimensional imag-
ing (after 2000) to target the lesion and spare the skin and
adjacent structures.39 In our study, we found that lesions
treated by CAS occurred on average 6 years after cervical
irradiation, compared with 2 years for open surgical lesions,
indicating perhaps that CAS patients received a less aggres-
sive form of irradiation. However, we found no differences
in the type of malignancy, radiation dose, or year in which
radiation was administered. Nonetheless, we found that
patients with prior radical neck dissections had higher rates
of stroke, cranial nerve injuries, wound complications, re-
stenosis, and reinterventions, although some of these dif-
ferences did not reach statistical significance.
Carotid artery stenting has clear advantages in the
hostile neck, but its use as the sole method of revascular-
ization for radiation-induced stenosis should be ques-
tioned. A history of previous radical neck dissection, trache-
ostomy, and neck examination indicating significant soft
tissue and skin induration or scar should discourage one
from open surgery. However, open carotid reconstruction
may be the best option in the patient who does not have
significant radiation damage to the skin or soft tissue,
particularly if other anatomical factors are not favorable for
stent placement (difficult arch, tortuosity, or thrombus). If
an open reconstruction is selected, we prefer to use a
carotid endarterectomy and patch angioplasty whenever
possible. However, this contrasts with other surgical series
where bypass with saphenous vein was the most common
type of reconstruction.21,22 We usually use an interposition
graft or bypass for longer lesions or in patients with friable
or thin-walled arteries after endarterectomy. The type of
patch or graft material may affect restenosis rate, based on
prior reports.21,22 All four patients with restenosis after
open repair in our study had polyester patches or grafts,
while there were no restenosis among those treated with
vein grafts or bovine pericardial patches. Other authors
have also reported a preference for autologous veins to
reconstruct radiation-induced lesions.21,22 A compelling
reason for selecting vein, in addition to less restenosis, is
their resistance to infection.5,21
The main cause of late death in our study was malig-
nancy, regardless of the type of treatment. Patient survival,
however, was significantly less after CAS compared with
open surgery. This is likely due to patient selection, which
has changed over the last decade; carotid stents allowed
treatment of patients who were previously denied open
surgery because of a hostile neck. This is evident by the
higher rates of tracheostomy and a trend towards more
radical neck dissections in the CAS group. It is likely that
selection bias has accounted for some the differences in
outcomes which favored open repair, including patient
survival and restenosis rates.
This study has other shortcomings that need to be
discussed. Because of the retrospective design and longtudy period, the exact circumstances involved in decision-
aking of type of treatment (stent vs open surgery) or
ethod of surgical reconstruction (endarterectomy vs by-
ass) cannot be determined. Because of the small number
f patients, differences in subgroup analysis may have not
eached statistical significancy because of type II error. It is
ossible that other factors such as radiation dose, number
f treatment sessions, and type of anti-platelet therapy
ould have accounted for some of the differences in reste-
osis rates and neurological events. Restenosis after open
urgical repair may have been underestimated because of
ess rigid follow-up compared with CAS patients, who
articipated in a prospective institutional registry. Con-
ersely, the strength of the study relies on a relative large
umber of patients given the rarity of RICS, and the quality
f data in our CAS group, which had independent neuro-
ogical examination and close monitoring with duplex US
maging.
Open carotid repair for RICS was associated with
igher rates of cranial nerve injury and a trend towards
ore wound complications compared with carotid stent-
ng. These complications occurred more frequently among
atients with previous neck dissections. However, the
igher rates of late neurologic events, restenosis, and rein-
erventions after carotid stenting may offset its benefits in
atients who do not have excessive radiation damage to the
kin and soft tissue, and who are potentially good candi-
ates for open carotid reconstruction.
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neck wound.
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Volume 53, Number 3 Tallarita et al 636.e1Fig 2, online only. Technique of pectoralis major myoc
(arrow). An island of skin and soft tissue is selected in th
pectoralis muscle attachments from the anterior chest wal
humerus (laterally). The flap is rotated 180 degrees and
Closed-drainage system is used in the anterior chest andutaneous flap coverage based on the thoracoacromial pedicle
e inframammary region. The flap is elevated by dividing the
l (inferiorly), sternum (medially), clavicle (superiorly), and the
advanced through the subcutaneous tunnel up to the neck.
JOURNAL OF VASCULAR SURGERY
March 2011636.e2 Tallarita et alFig 3, online only. Technique of carotid artery stenting (CAS) in
a 77-year-old male with prior cervical irradiation, radical neck
dissection, and tracheostomy who presented with progressive
high-grade left common and internal carotid artery stenosis (A).
Cervical angiography confirmed tandem lesions involving the left
common carotid artery (B, two arrows) and the proximal internal
carotid artery (B, curved arrow). Completion angiography (C)
after CAS with good anatomical result.
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 3 Tallarita et al 636.e3Table II, online only. Extent of carotid disease in 60 patients treated for 73 radiation-induced carotid stenosis with
carotid artery stenting (CAS) or open carotid repair (OR)
CAS OR
P valuea
RND n  24
patients/28
lesions, %
RND n  9
patients/9
lesions, %
RND n  11
patients/14
lesions, %
RND n  16
patients/22
lesions, %
Right side 13 (44) 2 (25) 8 (57) 9 (41) .6
Left side 16 (55) 6 (75) 6 (43) 13 (59) .6
Stenosis 50-79 5 (17) 1 (13) 0 (0) 0 (0) .03
Stenosis 80 24 (83) 7 (88) 14 (100) 22 (100) .6
Ulceration 13 (45) 2 (5) 6 (43) 16 (73) .3
Fresh thrombus 0 (0) 0 (0) 2 (14) 3 (13.5) .02
Common carotid artery 5 (17) 3 (37) 0 (0) 4 (18) .4
Internal carotid artery-short lesion (2 cm) 4 (14) 2 (25) 3 (21) 3 (14) 1.0
Internal carotid artery-long lesion (2 cm) 12 (41) 2 (25) 6 (43) 8 (36) 1.0
Common and internal carotid arteries 8 (28) 1 (13) 5 (36) 7 (32) .6
RND, Radical neck dissection present (RND) or absent (RND).
aP value for comparison of totals between carotid artery stenting and open carotid repair patients; comparisons of RND and RND patients were not
significant.
JOURNAL OF VASCULAR SURGERY
March 2011636.e4 Tallarita et alTable III, online only. Procedural characteristics in 60 patients treated for 73 radiation-induced carotid stenosis with
carotid artery stenting (CAS) or open repair (OR)
OR
P value
RND n  11
patients/14 lesions
RND n  16
patients/22 lesions
n  14 % n  22 %
Difficult dissection 5 36 5 23 .72
Difficult plaque cleavage plane 1 7 6 27 .39
Difficult dissection  difficult plaque cleavage plane 0 0 1 4.5 1.0
Myocutaneous flap coverage 3 22 0 0 .07
Reconstruction technique
Carotid endarterectomy  patch angioplasty 12 86 17 77 .88
Interposition segment 2 14 3 14 1.0
Ascending aorta-carotid bypass 0 0 2 9 .52
Total conduit 2 — 5 — .6
Saphenous vein graft 2 100 1 20 .5
Polytetrafluoroethylene 0 0 2 40 1.0
Polyester 0 0 2 40 1.0
Total patch 11 — 17 — 1.0
Polyester patch 4 36 13 76 .3
Bovine patch 6 54 1 8 .02
Saphenous vein patch 1 10 3 16 .6
CAS
RND n  24
patients/28 lesions %
RND n  9
patients/9 lesions %
Predilatation alone 23 84 5 64 .71
Pre- and postdilatation 3 7 2 24 .54
Postdilatation alone 2 6 0 0 1.0
Embolic protection device 19 65 6 75 .8
Type of stent
precise Rx 20 56 8 72 .52
Wallstent 9 26 2 18 .8
Acculink 3 9 1 9 1.0
SMART 1 3 0 0 1.0
Balloon expandable stent 1 3 0 0 1.0
Mean of stent for procedure 1.2  0.4 1.3  0.5 .3
Mean length (mm  SD) 30  7.6 27.0  4.7 .29
Mean diameter (mm  SD) 7.6  1.2 9.8  4.3 .65
Residual stenosis  20% 24 86 6 75 .87
Residual stenosis 20-40% 4 14 2 25 .61RND, Radical neck dissection present (RND) or absent (RND).
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 3 Tallarita et al 636.e5Fig 5, online only. Kaplan-Meier estimates for patient survival
among 60 patients treated for radiation-induced carotid stenosis
with open carotid repair (OR, red) or carotid artery stenting (CAS,
black). The dotted line denotes a standard deviation 10%.
